Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.954 EUR | +0.74% | +2.14% | -12.32% |
Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Apr. 29 | ApotekstjÄNst Sverige Ab cancelled the acquisition of Svensk Dos AB. | CI |
Sales 2024 * | 1.55B 1.68B | Sales 2025 * | 1.59B 1.73B | Capitalization | 178M 193M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 16M 17.35M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | 5.3M 5.75M | Net cash position 2025 * | 23.36M 25.33M | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
10.6
x | Employees | 800 |
Yield 2024 * |
8.39% | Yield 2025 * |
9.08% | Free-Float | 70.11% |
Latest transcript on Oriola Oyj
1 day | +0.74% | ||
1 week | +2.14% | ||
1 month | +6.59% | ||
3 months | -13.74% | ||
6 months | -8.62% | ||
Current year | -12.32% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 11-12-31 | |
Director of Finance/CFO | 54 | 22-11-30 | |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 22-12-31 | |
Director/Board Member | 55 | 22-12-31 | |
Harri Pärssinen
BRD | Director/Board Member | 61 | 19-01-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.954 | +0.74% | 61,923 |
24-05-30 | 0.947 | +0.96% | 38,929 |
24-05-29 | 0.938 | -0.64% | 45,026 |
24-05-28 | 0.944 | -0.84% | 53,979 |
24-05-27 | 0.952 | +1.93% | 75,897 |
Delayed Quote Nasdaq Helsinki, May 31, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.32% | 193M | |
+23.03% | 74.04B | |
-1.52% | 24.18B | |
+3.67% | 8.46B | |
+8.55% | 8.34B | |
-23.71% | 7.64B | |
+15.20% | 5.33B | |
-6.90% | 3.92B | |
+2.68% | 4.12B | |
+5.56% | 3.89B |
- Stock Market
- Equities
- OKDBV Stock